CNBC's Kate Kelly reports that David Einhorn's Greenlight Capital has increased their stake in Apple alongside other moves for Community Health, Chicago Bridge and Iron and The Chemours Company. » Read More
With bulls finally pushing the S&P to pre-Lehman levels, is anything left to drive stocks higher from here?
Stocks ended the week higher despite lack of progress on a tax bill as investors looked to positive economic and corporate news. GE and Pfizer rose, while Kraft and Boeing fell.
Stocks gained Friday following a handful of positive economic news and after GE boosted its quarterly dividend for the second time this year. GE and Pfizer rose, while Kraft and Boeing fell.
Stocks gained after General Electric boosted its quarterly dividend. Stocks had been fluctuating in a narrow range Friday despite a better-than-expected reading of consumer confidence, and a narrowing of the U.S. trade deficit in October.
Community Health’s offer for Tenet Healthcare is an effort to become a leader in the for-profit hospital sector, the New York Times reports.
U.S. stock index futures eased gains ahead of the open Friday after the U.S. trade deficit narrowed more than expected in October as investors focused on slowing U.S. demand.
The "Fast Money" traders discuss Community Health's $3.3 billion play for rival Tenet.
While the historic health care vote dominated headlines, we are seeing weakness this morning out of Asia, where India's Sensex Index dropped 1 percent in response to Friday's quarter point rate hike. There's also weakness in Europe, as Greece is down another 3.2 percent on uncertainty about what, if any, support Greece may get with its debt crisis...
Wall Street has done a bit of an about-face on health care reform in the past few weeks—while the Street for the most part is strongly opposed to the bill, analysts are increasingly pointing out potential positives in addition to negatives.
House Democrats are pushing to pass the health care bill as Pres. Obama seeks to rally recalcitrant congresspeople. Which stocks and sectors actually stand to benefit from the bill? Les Funtleyder, health care strategist at Miller Tabak, Jason Gurda, managed care analyst at Leerink Swann and Ralph Giacobbe, analyst at Credit Suisse First Boston offered their insights and investment recommendations.
Option activity is heating up for a second day in Universal Health Services, as investors look for the stock to rally over the next two months.
Time magazine's Man of the Year Ben Bernanke gave a speech this past weekend, and at first I thought he was defending the excessively loose monetary policy that led to the recent crisis.
President Barack Obama's health care overhaul cleared its second test in the Senate Tuesday. How is Washington action affecting stocks? Sheryl Skolnick, senior VP and health care analyst at Pali Capital, and Les Funtleyder, health care strategist at Miller Tabak, shared their insights.
There is nothing in this bill that changes our views at Soleil regarding the health care stocks we have been recommending.
Buy the IPO, Cramer says, because the company in an industry powerhouse.
The day after President Obama’s impassioned speech for big-government health care, Wall Street bet heavily that the so-called government-insurance option he supports is dead.
Economic news on Tuesday came early and left little impression. The news from overseas was actually more encouraging than the domestic variety
CNBC's "Power Lunch" team asked some of the best and the brightest from America's big financial firms to list the most promising stocks. Strategists from Citigroup, Goldman Sachs, Cowen & Co. and Deutsche Bank offered CNBC their stock picks.
If Democrats pull ahead in the race for the White House the team at Goldman has a trade for you.
As the push for universal health care in the U.S. heats up on Capitol Hill, market experts say generic drug stocks and pharmaceutical distributors should perform well, while the hit to big pharma may not be as bad as some anticipate.